Navigation Links
Cardinal Health Supports ACRIN Clinical Trials Evaluating Oncologic Biotracers
Date:6/3/2010

lass="discStyle" type="disc">
  • Two clinical trials assessing FLT-PET. One will evaluate its ability to assess whether chemotherapy treatments have been successful in reducing tumors prior to surgery in patients with locally advanced breast cancer. The other will use FLT-PET and advanced MRI sequences to assess whether imaging biotracers can be useful in predicting the likelihood of survival among patients with glioblastoma tumors.

  • Cardinal Health's Nuclear Pharmacy Services business operates more than 30 cyclotrons throughout the United States. These machines manufacture the high-energy PET imaging agents that allow internal images to be taken of the body. Cardinal Health cyclotrons are strategically located throughout the country to enable nearly 100 of the company's 160 radiopharmacies to compound and dispense high-energy, PET imaging agents in unit-dose form. Cardinal Health's vast network of "PET-enabled" pharmacies, combined with its comprehensive fleet and logistics capabilities, play a critical role in enabling patients, hospitals, clinics and research facilities to participate in innovative clinical trials of both proprietary and non-proprietary imaging agents.

    "Cardinal Health's extensive nuclear pharmacy expertise and its broad network of PET manufacturing and distribution sites make it an important partner in enabling ACRIN to conduct clinical trials using novel PET imaging probes," said David Mankoff, MD, PhD, chair of ACRIN's Experimental Imaging Sciences Committee and professor of radiology in the nuclear medicine department at the University of Washington. "Cardinal Health is playing a critical role in helping ACRIN find new ways to leverage imaging probes such as Sodium Fluoride, FMISO and FLT to assess the efficacy of cancer treatments."


    '/>"/>

    SOURCE Cardinal Health, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6

    Related medicine technology :

    1. Cardinal Health Releases New Tool to Combat MRSA Infections in Hospitals
    2. Stem Cell Breakthrough Advances Science Without Ethical Landmines, Says Cardinal
    3. Hydrox Inc., Cardinal Health Issue Nationwide Recall of Alcohol-Free Mouthwash For Hospitals
    4. Cardinal Health Completes Enturia Acquisition
    5. Cardinal Health Expands PET Nuclear Pharmacy Services to Support Clinical Drug Trials
    6. AmeriCares Honors Cardinal Health with Power of Partnership Award
    7. Cardinal Health Helps Hospitals Save More Than $20 Million In Pharmaceutical Costs; Connect Low-Income Patients With Affordable Medications
    8. Cardinal Health Executives to Speak at Two Investor Events in January
    9. Cardinal Health Names Carrie Cox to Board of Directors
    10. Cardinal Health Raises Quarterly Dividend By 11 Percent
    11. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/28/2015)... July 28, 2015  SeraCare Life Sciences, a ... announced today at the American Association of Clinical ... licensing agreement with the University of California, San ... (T21), Trisomy 18 (T18) and Trisomy 13 (T13) ... creating "patient-like" reference materials for Non-Invasive Prenatal Testing ...
    (Date:7/28/2015)... Ala. , July 28, 2015   Vincari ... for surgeons , has just hired John O,Neil ... Business Development. John has over 30 years of diverse ... roles. Mr. O,Neil,s executive healthcare experience coupled with Vincari,s ... active surgeon allows Vincari to address the challenges both ...
    (Date:7/28/2015)... 2015 The Canadian International Pharmacy ... Canadian Anti-Fraud Centre (CAFC), continues to aggressively ... CIPA verification seal on illegitimate pharmacy websites.  The ... pharmacy member companies who have maintained a 100% ... than 10 million Americans since 2002. ...
    Breaking Medicine Technology:SeraCare Life Sciences Signs License Agreement with UCSF and Announces Early Access Program for Development of Aneuploidy Reference Materials 2SeraCare Life Sciences Signs License Agreement with UCSF and Announces Early Access Program for Development of Aneuploidy Reference Materials 3John O'Neil Joins Vincari as Executive Vice President of Strategy and Business Development 2Canadian International Pharmacy Association (CIPA) Continues to Fight Rogues Fraudulently Using the Trusted CIPA Verification Seal 2Canadian International Pharmacy Association (CIPA) Continues to Fight Rogues Fraudulently Using the Trusted CIPA Verification Seal 3
    ... RA Signs and Symptoms Compared to Placebo, ... (Nasdaq: TRBN ) today announced preliminary ... double-blind, placebo-controlled, multicenter,clinical trial of its TRU-015 ... indicated that Trubion,s TRU-015 product candidate, at,well-tolerated ...
    ... Calif., Sept. 10 Peregrine,Pharmaceuticals, Inc. (Nasdaq: ... antibodies for the treatment of cancer and,hepatitis C ... submitted a,clinical protocol with the Drug Controller General ... safety and efficacy trial of bavituximab in combination,with ...
    Cached Medicine Technology:Trubion Announces Preliminary Analysis of Phase IIb Results With TRU-015 in Rheumatoid Arthritis 2Trubion Announces Preliminary Analysis of Phase IIb Results With TRU-015 in Rheumatoid Arthritis 3Trubion Announces Preliminary Analysis of Phase IIb Results With TRU-015 in Rheumatoid Arthritis 4Trubion Announces Preliminary Analysis of Phase IIb Results With TRU-015 in Rheumatoid Arthritis 5Peregrine Pharmaceuticals Submits Clinical Protocol to Initiate Bavituximab Phase II Trial in Patients With Metastatic Breast Cancer 2Peregrine Pharmaceuticals Submits Clinical Protocol to Initiate Bavituximab Phase II Trial in Patients With Metastatic Breast Cancer 3Peregrine Pharmaceuticals Submits Clinical Protocol to Initiate Bavituximab Phase II Trial in Patients With Metastatic Breast Cancer 4
    (Date:7/29/2015)... (PRWEB) , ... July 29, 2015 , ... ... a decision from the Judicial Panel on Multidistrict Litigation (JPML), according to court ... defects research at their website, the Zofran Birth Defects Lawsuit Center. , GlaxoSmithKline, ...
    (Date:7/29/2015)... Carolina (PRWEB) , ... July 29, 2015 , ... ... MetLife, Inc ., a global provider of life insurance, annuities, employee benefits and ... Challenge North Carolina inclusive sporting event taking place in Charlotte, North Carolina ...
    (Date:7/29/2015)... , ... July 29, 2015 , ... ... the first dermatologist in Sarasota to be chosen by the manufacturer to offer ... offers the first injectable, non-invasive way to treat and eliminate double chin fat,” ...
    (Date:7/29/2015)... ... July 29, 2015 , ... Nature’s Artisan, a new ... of gourmet flavors. , Nature’s Artisan was founded by Tina Yarandi, who came up ... the UCLA School of Dentistry. Tina was amazed when she learned about the incredible ...
    (Date:7/28/2015)... MD (PRWEB) , ... July 28, 2015 , ... Every ... most kids with the disease only experience through movies and television. They go to ... failure of the right side of the heart as it pushes hard to get ...
    Breaking Medicine News(10 mins):Health News:Zofran Lawsuit News: Zofran Lawsuits Stayed, Awaiting MDL Decision 2Health News:Zofran Lawsuit News: Zofran Lawsuits Stayed, Awaiting MDL Decision 3Health News:Zofran Lawsuit News: Zofran Lawsuits Stayed, Awaiting MDL Decision 4Health News:MetLife Joins World T.E.A.M. Sports’ Adventure Team Challenge North Carolina as Presenting Sponsor 2Health News:MetLife Joins World T.E.A.M. Sports’ Adventure Team Challenge North Carolina as Presenting Sponsor 3Health News:SkinSmart Dermatology is First in Sarasota to Offer Kybella Treatments to Reduce Double Chin Fat 2Health News:SkinSmart Dermatology is First in Sarasota to Offer Kybella Treatments to Reduce Double Chin Fat 3Health News:Discover a New Take on Oral Care with Nature’s Artisan Gourmet Mouthwashes 2Health News:Special Summer Camp Gives Pulmonary Hypertension Patients Experiences Typically Out of Reach for Kids with their Condition 2Health News:Special Summer Camp Gives Pulmonary Hypertension Patients Experiences Typically Out of Reach for Kids with their Condition 3
    ... of research and billions of dollars, cancer remains a ... the body,s defenses and medical intervention. Now an Arizona ... "Cancer is not a random bunch of selfish rogue ... stress, honed by a long period of evolution," claims ...
    ... in the genome are the cause of many diseases. Gene ... copies offers a means of correcting such defects. Now ... University of Munich, and led by Privatdozent Dr. Carsten Rudolph, ... team shows for the first time that chemical modification of ...
    ... hundreds of proteins produced by the DNA of tumor ... central to a new treatment for the often-fatal childhood ... pediatric clinical trials of a drug that blocks the ... a promising treatment target for high-risk neuroblastoma," said pediatric ...
    ... 7 (HealthDay News) -- Heart attack patients who are exposed ... have an increased risk of cancer, a new study finds. ... a heart attack between April 1996 and March 2006 and ... heart attack, 77 percent of the patients underwent at least ...
    ... News) -- In cold weather, older adults are especially vulnerable ... take steps to prevent this potentially deadly condition. Hypothermia ... remains there for an extended length of time. As people ... of exposure to cold, according to the U.S. National Institute ...
    ... -- The amount of money spent on psychiatric drugs in ... slower rate than in previous years, a new federal government ... psychiatric drugs rose 5.6 percent, compared with an increase of ... Abuse and Mental Health Services Administration. The agency,s analysis ...
    Cached Medicine News:Health News:Conceptualizing cancer cells as ancient 'toolkit' 2Health News:Save messengers -- modified mRNAs open up new therapeutic possibilities 2Health News:Protein may be key to new treatment in a childhood cancer 2Health News:Protein may be key to new treatment in a childhood cancer 3Health News:Heart Scans May Raise Cancer Risk, Study Finds 2Health News:Seniors Vulnerable to Hypothermia 2Health News:U.S. Sees Slowdown in Spending on Mental Health 2
    Ideal for abdominal, hip, thigh and knee procedures....
    Body Suit w/Bra above knee...
    Gynecomastia Vest...
    Male Compression Vest, Front Closure...
    Medicine Products: